Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Geron Corp (NASDAQ: GERN) closed the day trading at $1.4 down -4.76% from the previous closing price of $1.47. In other words, the price has decreased by -$4.76 from its previous closing price. On the day, 9.03 million shares were traded. GERN stock price reached its highest trading level at $1.48 during the session, while it also had its lowest trading level at $1.38.
Ratios:
For a better understanding of GERN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.79 and its Current Ratio is at 7.87. In the meantime, Its Debt-to-Equity ratio is 0.96 whereas as Long-Term Debt/Eq ratio is at 0.89.
On May 08, 2025, Scotiabank Downgraded its rating to Sector Perform which previously was Sector Outperform but kept the price unchanged to $1.50.
B. Riley Securities Downgraded its Buy to Neutral on February 27, 2025, whereas the target price for the stock was revised from $3.50 to $2.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 09 ’25 when LAWLIS V BRYAN bought 13,300 shares for $1.18 per share. The transaction valued at 15,667 led to the insider holds 13,300 shares of the business.
Samuels Scott Alan bought 15,000 shares of GERN for $24,150 on Feb 27 ’25. The EVP, Chief Legal Officer now owns 26,682 shares after completing the transaction at $1.61 per share. On Feb 27 ’25, another insider, SCARLETT JOHN A, who serves as the Chairman, President and CEO of the company, bought 12,500 shares for $1.76 each. As a result, the insider paid 22,062 and bolstered with 12,500 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GERN now has a Market Capitalization of 893223808 and an Enterprise Value of 627085888. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.43 while its Price-to-Book (P/B) ratio in mrq is 3.44. Its current Enterprise Value per Revenue stands at 3.813 whereas that against EBITDA is -8.145.
Stock Price History:
The Beta on a monthly basis for GERN is 0.57, which has changed by -0.6728972 over the last 52 weeks, in comparison to a change of 0.1716845 over the same period for the S&P500. Over the past 52 weeks, GERN has reached a high of $4.82, while it has fallen to a 52-week low of $1.09. The 50-Day Moving Average of the stock is 3.47%, while the 200-Day Moving Average is calculated to be -33.34%.
Shares Statistics:
Over the past 3-months, GERN traded about 9.73M shares per day on average, while over the past 10 days, GERN traded about 5561790 shares per day. A total of 637.85M shares are outstanding, with a floating share count of 604.37M. Insiders hold about 5.27% of the company’s shares, while institutions hold 76.75% stake in the company. Shares short for GERN as of 1755216000 were 86667584 with a Short Ratio of 8.91, compared to 1752537600 on 67960999. Therefore, it implies a Short% of Shares Outstanding of 86667584 and a Short% of Float of 14.2.
Earnings Estimates
The company has 3.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.03, with high estimates of -$0.02 and low estimates of -$0.04.
Analysts are recommending an EPS of between -$0.09 and -$0.13 for the fiscal current year, implying an average EPS of -$0.11. EPS for the following year is -$0.02, with 4.0 analysts recommending between $0.03 and -$0.06.
Revenue Estimates
8 analysts predict $55.24M in revenue for the current quarter. It ranges from a high estimate of $58.9M to a low estimate of $52.84M. As of the current estimate, Geron Corp’s year-ago sales were $28.27MFor the next quarter, 8 analysts are estimating revenue of $62.34M. There is a high estimate of $70.8M for the next quarter, whereas the lowest estimate is $57.04M.
A total of 8 analysts have provided revenue estimates for GERN’s current fiscal year. The highest revenue estimate was $218.3M, while the lowest revenue estimate was $199.06M, resulting in an average revenue estimate of $206.4M. In the same quarter a year ago, actual revenue was $76.99MBased on 8 analysts’ estimates, the company’s revenue will be $324.12M in the next fiscal year. The high estimate is $413.2M and the low estimate is $266.39M.
